N-Caffeoyl O-methyltyramine

CAS No. 189307-47-9

N-Caffeoyl O-methyltyramine( —— )

Catalog No. M26313 CAS No. 189307-47-9

N-Caffeoyl O-methyltyramine is isolated from Cuscuta reflexa with strong inhibitory activity against α-glucosidase with IC50 of 103.58 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 115 Get Quote
10MG 177 Get Quote
25MG 372 Get Quote
50MG 556 Get Quote
100MG 791 Get Quote
500MG 1611 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    N-Caffeoyl O-methyltyramine
  • Note
    Research use only, not for human use.
  • Brief Description
    N-Caffeoyl O-methyltyramine is isolated from Cuscuta reflexa with strong inhibitory activity against α-glucosidase with IC50 of 103.58 μM.
  • Description
    N-Caffeoyl O-methyltyramine is isolated from Cuscuta reflexa with strong inhibitory activity against α-glucosidase with IC50 of 103.58 μM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cytoskeleton/Cell Adhesion Molecules
  • Target
    Glucokinase
  • Recptor
    Wnt/β-catenin
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    189307-47-9
  • Formula Weight
    313.353
  • Molecular Formula
    C18H19NO4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 250 mg/mL (797.83 mM)
  • SMILES
    COc1ccc(CCNC(=O)\C=C\c2ccc(O)c(O)c2)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Ting Wang, et al. N-(3-methoxybenzyl)-(9Z,12Z,15Z)-octadecatrienamide promotes bone formation via the canonical Wnt/β-catenin signaling . pathwayPhytother Res. 2019 Apr;33(4):1074-1083.
molnova catalog
related products
  • PF-04991532

    PF-04991532 (PF4991532) is a potent, hepatoselective Glucokinase (GK) activator with EC50 of 90±45 nM.

  • KAN0438757

    KAN0438757 is a selective and potent inhibitor of the metabolic kinase PFKFB3 with an IC50 of 0.19 μM.

  • ARRY-403

    ARRY-403 is a novel glucokinase activator that reduces fasting and postprandial blood glucose in patients with type 2 diabetes.